Loading provider…
Loading provider…
Hematology (Internal Medicine) Physician in Boston, MA
NPI: 1043308570Primary Practice Location
BETH ISRAEL DEACONESS MEDICAL CENTER
330 Brookline Ave, Boston, MA
Primary Employer
Lahey Clinic
bilh.org
HQ Phone
Get MD Arthur's Phone Numberphone_androidMobile
Get MD Arthur's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 28 | 73 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 20 | 23 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 18 | 44 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 15 | 15 |
Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia.
Authors: Alexey Danilov, Olga Danilova, Jennifer Brown, Arthur Rabinowitz, Andreas Klein, Brigitte Huber
Publication Date: 2010-07-22
Authors: Chai, Wanxing, Chaudhry, Abrar, Rabinowitz, Arthur P
Journal: J Clin Apher
Publication Date: 2014-04-30
Lead Sponsor: AbbVie
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Venetoclax, DRUG: Dexamethasone, DRUG: Bortezomib, DRUG: Placebo for venetoclax
Lead Sponsor: AbbVie
Collaborators: Roche-Genentech
Intervention / Treatment: DRUG: Venetoclax, DRUG: Dexamethasone, DRUG: Pomalidomide
Lead Sponsor: AbbVie
Collaborators: Genentech, Inc.
Intervention / Treatment: DRUG: Rituximab, DRUG: ABT-199